MannKind | MNKD - 市值

金融业

USD

USD 792.18M

现金及等价物

USD 74.88M

USD 33.65M

USD 291.58M

USD 171.03M

USD 119.91M

USD -69.24M

USD 17.92M

407

EPS每股收益

USD 0.01

股本和储备

USD -51.02M

USD 78.31M

债务利息支出

USD 13.87M

USD 2.63M

USD 548.44M

USD 711.2M

USD -15.95M

USD 119.65M

USD -69.24M

普通股股本

USD 307.83M

303.7

USD -20.93M

USD 111.96M

销售和管理费用

USD 29.09M

USD 35.31M

贸易债权人

USD 9.03M

应收帐款人

USD 38.37M

	市值	更改		日
Adma Biologics	USD 4.34B		845M	2025-12
BioCryst Pharmaceuticals	USD 1.66B		64M	2025-12
Eli Lilly	USD 1.02T		293.84B	2025-12
Halozyme Therapeutics	USD 7.91B		664M	2025-12
Insmed	USD 37.12B		6.68B	2025-12
Karyopharm Therapeutics	USD 652M		517M	2026-04
MacroGenics	USD 102M		4M	2025-12
MannKind	USD 1.74B		93M	2025-12
Merck	USD 261.26B		51.62B	2025-12
Novavax	USD 1.09B		316M	2025-12
Pfizer	USD 141.57B		6.48B	2025-12
Sanofi	EUR 101.43B		1.16B	2026-04
Xencor	USD 1.09B		256M	2025-12